These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37491713)

  • 1. Thiopurines Maintenance Therapy in Children With Ulcerative Colitis: A Multicenter Retrospective Study.
    Abu Hanna F; Atia O; Yerushalmy Feler A; Shouval D; Weiss B; Mresat H; Magen-Rimon R; Zifman E; Turner D; Rinawi F
    J Pediatr Gastroenterol Nutr; 2023 Oct; 77(4):505-511. PubMed ID: 37491713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy.
    Iizuka M; Etou T; Sagara S
    World J Gastroenterol; 2022 Sep; 28(34):4959-4972. PubMed ID: 36160647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and maintenance infliximab therapy in children with moderate to severe ulcerative colitis: Retrospective, multicenter study.
    Iwańczak BM; Kierkuś J; Ryżko J; Szczepanik M; Więcek S; Czaja-Bulsa G; Kacperska M; Korczowski B; Maślana J; Iwańczak F
    Adv Clin Exp Med; 2017; 26(1):57-61. PubMed ID: 28397433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis.
    Singh S; Allegretti JR; Siddique SM; Terdiman JP
    Gastroenterology; 2020 Apr; 158(5):1465-1496.e17. PubMed ID: 31945351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of remission and indicators of inadequate response to advanced therapy in patients with ulcerative colitis: results from medical charts in the United Kingdom.
    Lindsay JO; Picker N; Kromer D; Smyth M; Patel H
    Curr Med Res Opin; 2023 May; 39(5):681-689. PubMed ID: 36951899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome following infliximab therapy in children with ulcerative colitis.
    Hyams JS; Lerer T; Griffiths A; Pfefferkorn M; Stephens M; Evans J; Otley A; Carvalho R; Mack D; Bousvaros A; Rosh J; Grossman A; Tomer G; Kay M; Crandall W; Oliva-Hemker M; Keljo D; LeLeiko N; Markowitz J;
    Am J Gastroenterol; 2010 Jun; 105(6):1430-6. PubMed ID: 20104217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes Following Acute Severe Colitis at Initial Presentation: A Multi-centre, Prospective, Paediatric Cohort Study.
    Dhaliwal J; Tertigas D; Carman N; Lawrence S; Debruyn JC; Wine E; Church PC; Huynh HQ; Rashid M; El-Matary W; Deslandres C; Critch J; Ricciuto A; Carroll MW; Benchimol EI; Muise A; Jacobson K; Otley AR; Vallance B; Mack DR; Walters TD; Surette MG; Griffiths AM
    J Crohns Colitis; 2024 Feb; 18(2):233-245. PubMed ID: 37602969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.
    Armuzzi A; Pugliese D; Danese S; Rizzo G; Felice C; Marzo M; Andrisani G; Fiorino G; Nardone OM; De Vitis I; Papa A; Rapaccini GL; Guidi L
    Inflamm Bowel Dis; 2014 Aug; 20(8):1368-74. PubMed ID: 24983979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients.
    Schmidt KJ; Herrlinger KR; Emmrich J; Barthel D; Koc H; Lehnert H; Stange EF; Fellermann K; Büning J
    Aliment Pharmacol Ther; 2013 Jan; 37(1):129-36. PubMed ID: 23121200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of patients with acute ulcerative colitis after first course of intravenous corticosteroids.
    Eronen H; Ilus T; Jussila A; Huhtala H; Collin P; Oksanen P
    Scand J Gastroenterol; 2021 Mar; 56(3):234-238. PubMed ID: 33496198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.
    Turner D; Griffiths AM; Veerman G; Johanns J; Damaraju L; Blank M; Hyams J
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1460-5. PubMed ID: 23672831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal.
    Moreno-Rincón E; Benítez JM; Serrano-Ruiz FJ; Vázquez-Morón JM; Pallarés-Manrique H; Herrera-Justiniano JM; Leo-Carnerero E; Gómez-García MR; Cabello-Tapia MJ; Castro-Fernández M; Rojas-Feria M; Castro-Laria L; Argüelles-Arias F; Camargo-Camero R; Alcaín-Martínez G; Iglesias-Flores E; García-Sánchez V
    Inflamm Bowel Dis; 2015 Jul; 21(7):1564-71. PubMed ID: 26070002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sustained combination therapy for at least 6 months with thiopurines and infliximab in patients with ulcerative colitis in clinical remission: a retrospective multicenter French experience.
    Filippi J; Laharie D; Michiels C; Flamand M; Bouguen G; Nancey S; Presles E; Paul S; Schneider S; Hébuterne X; Roblin X
    J Crohns Colitis; 2015 Mar; 9(3):252-8. PubMed ID: 25588386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis.
    Moore H; Dolce P; Devas N; Baldassano R; Martinelli M
    United European Gastroenterol J; 2020 May; 8(4):425-435. PubMed ID: 32213038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis.
    Yamamoto S; Nakase H; Matsuura M; Masuda S; Inui K; Chiba T
    J Clin Gastroenterol; 2011 Jul; 45(6):526-30. PubMed ID: 21336140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of patients with acute severe ulcerative colitis treated with cyclosporine rescue therapy.
    Eronen H; Oksanen P; Jussila A; Huhtala H; Helavirta I; Ilus T
    Scand J Gastroenterol; 2023 May; 58(5):483-488. PubMed ID: 36384352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission.
    Armuzzi A; Pugliese D; Danese S; Rizzo G; Felice C; Marzo M; Andrisani G; Fiorino G; Sociale O; Papa A; De Vitis I; Rapaccini GL; Guidi L
    Inflamm Bowel Dis; 2013 Apr; 19(5):1065-72. PubMed ID: 23448790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab Rescue Therapy in Pediatric Severe Colitis.
    Stewart S; Briggs KB; Dekonenko C; Fraser JA; Svetanoff WJ; Oyetunji TA; Bass JA; St Peter SD
    J Pediatr Surg; 2023 Oct; 58(10):1893-1897. PubMed ID: 37349216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study.
    Fiorino G; Cortes PN; Ellul P; Felice C; Karatzas P; Silva M; Lakatos PL; Bossa F; Ungar B; Sebastian S; Furfaro F; Karmiris K; Katsanos KH; Muscat M; Christodoulou DK; Maconi G; Kopylov U; Magro F; Mantzaris GJ; Armuzzi A; Boscà-Watts MM; Ben-Horin S; Bonovas S; Danese S
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1426-1432.e1. PubMed ID: 27317850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar Short- and Long-term Colectomy Rates with Ciclosporin and Infliximab Treatment in Hospitalised Ulcerative Colitis Patients.
    Duijvis NW; Ten Hove AS; Ponsioen CI; van den Brink GR; Buskens CJ; Bemelman WA; Te Velde AA; D'Haens GR; Löwenberg M
    J Crohns Colitis; 2016 Jul; 10(7):821-7. PubMed ID: 26818660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.